Venom Detection Immunoassay for Brown Recluse Spider Bite Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for brown recluse spider bites are inadequate due to cross-reactivity issues with proteins from other arthropods and the difficulty in detecting sphingomyelinase D, a unique venom component responsible for dermal necrosis, leading to misdiagnoses and inappropriate treatments.
Innovation Solution
A method using a swab to collect venom samples from bite sites, followed by an ELISA assay with polyclonal antibodies specific to sphingomyelinase D, which reduces blocking antibodies and enhances sensitivity, allowing for accurate detection of Loxosceles venom even in the presence of other arthropod proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If routine ELISA construction is used to detect a single protein, then the assay is simple and straightforward, but it cannot detect sphingomyelinase D in venom containing multiple proteins with cross-reactivity issues
Solution Approach 1:
The patent extracts and isolates sphingomyelinase D from the complex venom mixture by using specific antibodies that bind only to this unique protein. This extraction approach allows detection of the target protein despite the presence of other interfering proteins in the venom, resolving the contradiction between detection accuracy and assay complexity.
Solution Approach 2:
The patent introduces polyclonal antibodies as intermediaries that specifically recognize sphingomyelinase D. These antibodies act as mediators between the complex venom sample and the detection system, enabling selective detection of the target protein while blocking cross-reactivity with other arthropod proteins, thus improving precision without excessive complexity.
2Measurement precision
If polyclonal antibodies are used to detect sphingomyelinase D, then sensitivity is enhanced and blocking antibodies are reduced, but the assay requires optimization to eliminate cross-reactivity with other arthropod proteins
Solution Approach 1:
The patent optimizes assay parameters including antibody concentration, incubation time, and blocking conditions to enhance sensitivity while eliminating cross-reactivity. By carefully adjusting these parameters, the assay achieves high sensitivity for sphingomyelinase D detection without false positives from other arthropod proteins, resolving the contradiction between sensitivity and ease of manufacture.
3Reliability
If misdiagnosis occurs due to cross-reactivity issues, then inappropriate treatments are administered, but accurate detection of sphingomyelinase D requires a specialized assay
Solution Approach 1:
The patent extracts the diagnostic value from complex venom samples by specifically isolating and detecting sphingomyelinase D, the unique protein responsible for dermal necrosis. This extraction approach ensures reliable diagnosis by focusing on the pathogenic component while ignoring other proteins that cause cross-reactivity, thereby improving reliability despite assay specialization.
Solution Approach 2:
The patent uses polyclonal antibodies as specific intermediaries that bridge the gap between complex venom samples and accurate diagnosis. These antibodies selectively bind to sphingomyelinase D, providing reliable diagnostic information while blocking interference from other proteins, thus achieving high reliability with a specialized but manageable assay.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise diagnosis of brown recluse spider bites, reducing morbidity and expense associated with incorrect diagnoses and treatments, and can be applied to detect other clinical relevant protein markers for various envenomations.
Implementation Method 1
collecting a sample comprising venom from the area of the suspected bite or sting using a swab
Implementation Method 2
contacting the sample with an antibody which specifically binds to an antigenic site on venom present in the sample; and detecting a complex formed by binding of the antibody and the antigenic site
Data Source
AI summary
Methods and immunoassays for diagnosing a bite or sting of a venomous organism in a patient having symptoms consistent with such a bite or sting are provided. A sample of venom is collected from the area of the suspected bite or sting using a swab and then contacted with an antibody that specifically binds to an antigenic site on venom present in the sample. Binding is then detected. The invention is illustrated by examples showing diagnosis of brown recluse spider bite, distinguishing it from other diagnoses with which it is often confused. This extremely sensitive test can detect venom antigens down to about 20 picograms even after the sample has been shipped and stored for periods of up to three weeks during the summer.